NLRP3 and CINCA syndrome: As mentioned above, in CINCA syndrome, about 90% of patients have constitutive or somatic mosaic mutations in NLRP3. However, the remaining 10% of patients with clinical symptoms of CINCA syndrome do not have mutations in the NLRP3 gene [35].